Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Vtrey-ER 250 Tablet

Prescription Icon
Prescription Required

Marketer

Earthmed Pharmaceutical Pvt Ltd

Salt Composition

Divalproex (250mg)

Overview Vtrey-ER 250 Tablet

Epileptic seizures and migraine prevention are key applications of the extended-release Valtoin 250mg tablet. It's also sometimes prescribed for bipolar disorder management, either independently or alongside other medications. Dosage and frequency are determined individually by your physician to optimize symptom control. Administer with or without food, consistently at the same time daily for maximum efficacy; full therapeutic effect generally takes several weeks. Continuous use, as directed, is crucial; missed doses can precipitate seizures, and abrupt cessation may worsen your condition. Gradual discontinuation is essential. Common side effects, often mild, include headache, visual blurring, nausea, vomiting, vertigo, fatigue, imbalance, easy bruising, and hypothermia. Continue treatment but report persistent or bothersome effects to your doctor. Immediate medical attention is warranted if a skin rash or redness develops. Prolonged use may result in osteoporosis, increasing fracture risk, and, in rare instances, may trigger suicidal ideation or behavior; report any mood deterioration to your physician. Prior to initiating therapy, inform your doctor of any history of cardiovascular issues, hepatic or renal impairment, urinary difficulties, depression, or suicidal tendencies. Drug interactions are possible; disclose all medications to ensure safety. Pregnant individuals should consult their physician before starting or stopping this medication. Alcohol consumption should be minimized due to potential side effect exacerbation and increased seizure risk. Regular blood monitoring, before and during treatment, assists in dose optimization.

Uses of Vtrey-ER 250 Tablet

Managing epileptic seizures and bipolar disorder, plus migraine prevention.

Major Benefits of Vtrey-ER 250 Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the tablet whole; do not crush, chew, or break it. Vtrey-ER 250 Tablets can be taken with or without food, however, consistent timing is recommended.

Common Side effects of Vtrey-ER 250 Tablet:

  • Decreased body temperature
  • Dizziness
  • Sleepiness
  • Tremors
  • Paresthesia (tingling or pricking sensation)
  • Anemia (low number of red blood cells)
  • Decreased sodium level in blood
  • Liver injury
  • Gastrointestinal disturbance
  • Hypersensitivity
  • Deafness
  • Urinary incontinence
  • Increase in body weight
  • Pain during periods

How to use Vtrey-ER 250 Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vtrey-ER 250 Tablets can be consumed with or without food, although consistent timing is recommended.

How Vtrey-ER 250 Tablet works:

Epileptic seizures are managed by Vtrey-ER 250 mg tablets, an anticonvulsant that reduces heightened, irregular neuronal firing in the brain.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Vtrey-ER 250 Tablet and alcohol may result in increased sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Vtrey-ER 250 Tablets during pregnancy poses a confirmed risk to the fetus. While generally contraindicated, a physician might exceptionally prescribe it in critical situations where the potential benefits outweigh the known dangers. Always seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Vtrey 250 mg tablets pose minimal risk during lactation. Research in humans indicates negligible transfer of the medication into breast milk, presenting no apparent danger to the infant.

DrivingDrivingUNSAFE

Driving ability may be impaired by side effects associated with Vtrey-ER 250 Tablet.

KidneyKidneySAFE IF PRESCRIBED

Vtrey-ER 250 Tablets pose no safety concerns for individuals with kidney impairment; no dosage modification is necessary.

LiverLiverUNSAFE

Patients with liver disorders should likely abstain from Vtrey-ER 250 Tablet due to potential safety concerns. Medical advice is recommended.

What if you forget to take Vtrey-ER 250 Tablet :

Should you forget a dose of Vtrey-ER 250 Tablet, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vtrey-ER 250 Tablet

LabelValue
Chemical Type Derivatives of Aliphatic Carboxylic Acids
Developing Habits No.
Type of Therapy Neuroscience Central Nervous System
Action Category Sodium channel-blocking antiepileptic drugs

FAQs on Vtrey-ER 250 Tablet

Always consult your doctor before discontinuing Vtrey-ER 250 Tablet. Withdrawal should be gradual, under medical supervision, to minimize the risk of symptom recurrence, including irritability, anxiety, dizziness, and tremors.
Vtrey-ER 250 Tablets are occasionally used to stabilize mood in patients experiencing rapid mood swings. They achieve this by reducing excessive brain activity associated with these fluctuations.
Weight gain is a possible side effect of Vtrey-ER 250 Tablet, potentially resulting from increased appetite. To minimize this, maintain a healthy diet and exercise regularly. Consult your doctor if weight gain is a concern.
Vtrey-ER 250 Tablet may cause drowsiness. Refrain from driving or activities requiring alertness until you understand its effects on you.
Hair loss is a possible, though typically temporary and dose-dependent, side effect of Vtrey-ER 250 Tablet. Consult your doctor if this occurs or continues.
Vtrey-ER 250 Tablet can cause liver damage, particularly within the first six months of treatment. Symptoms may include nausea, vomiting, appetite loss, stomach pain, dark urine, facial swelling, and jaundice (yellowing of skin or eyes). Liver function tests are crucial before starting and regularly during the initial six months, especially for at-risk individuals or those with pre-existing liver conditions.
Refrain from drinking alcohol during your Vtrey-ER 250 Tablet treatment. Combining alcohol with this medication may increase drowsiness, dizziness, or lightheadedness.
Before starting Vtrey-ER 250 Tablet treatment, your doctor may order blood tests. These may include a complete blood count (with platelets), bleeding time, and coagulation studies to help prevent bleeding or bruising. Liver function tests are also recommended before and during the first six months of treatment, particularly for patients with a history of liver problems or those considered at higher risk.
Severe abdominal pain, nausea, and vomiting may indicate pancreatitis. Seek immediate medical attention if you experience these symptoms. Your doctor may order a serum amylase test; if positive for pancreatitis, medication should be stopped immediately.
Vtrey-ER 250 Tablet overdose can lead to headaches, blurred vision (from constricted pupils), reduced reflexes, confusion, and fatigue. Further symptoms may include muscle weakness, seizures, unconsciousness, altered behavior, and respiratory problems like rapid breathing, shortness of breath, or chest pain. Seek immediate medical help if an overdose occurs.
Vtrey-ER 250 Tablet
64
MRP 74
13% off